Shares of Charles River Laboratories International Inc. slipped 4.91% to $165.35 Thursday, on what proved to be an all-around ...

Goldman Sachs downgraded contract research organizations Icon Public Limited (NASDAQ:ICLR) and Charles River Laboratories ...

Learn more about whether Charles River Laboratories International, Inc. or Stevanato Group S.p.A. is a better investment ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $174.3, a high estimate of $190.00 ...

Charles River Laboratories’s shares have sunk to $173.44, producing a disappointing 15.7% loss while the S&P 500 was flat.

Charles River Labs (CRL – Research Report) received a Hold rating and price target from Goldman Sachs analyst Matthew Sykes today. The ...

Goldman Sachs analyst Matthew Sykes downgraded Charles River (CRL) to Neutral from Buy with a price target of $170, down from $190. While the ...

Proficio Capital Partners LLC acquired a new position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – ...

Most readers would already be aware that Charles River Laboratories International's (NYSE:CRL) stock increased significantly by 15% over the past month. Given that stock prices are usually aligned ...

Shares of Charles River Laboratories International Inc. CRL rose 1.10% to $176.94 Tuesday, on what proved to be an all-around ...

Research analysts at Zacks Research decreased their Q1 2025 earnings per share (EPS) estimates for Charles River Laboratories ...

The stock's fall snapped a three-day winning streak.